ANDA 84393, held by Lannett. Nitrofurazone.
As of Nov 14, 2026, ANDA 84393 (Nitrofurazone), held by Lannett, was first approved by FDA on Jun 5, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 5, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Nitrofurazone0.2% ยท ointment;topical | Nitrofurazone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
